{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:38:02Z","timestamp":1792028282644,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det f\u00f6r h\u00e4lsa, arbetsliv och v\u00e4lf\u00e4rd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004037","name":"Juho Vainion S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021066","name":"Gates Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010114","name":"Yrj\u00f6 Jahnssonin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"IHI JU","doi-asserted-by":"publisher","award":["101132933"],"award-info":[{"award-number":["101132933"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"ADDF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101132933"],"award-info":[{"award-number":["101132933"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tjpad.2025.100367","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:24:19Z","timestamp":1761528259000},"page":"100367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Risk reduction and precision prevention across the Alzheimer\u2019s disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0373-7417","authenticated-orcid":false,"given":"Erika","family":"Bereczki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-3926","authenticated-orcid":false,"given":"Francesca","family":"Mangialasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagnese","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0901-9932","authenticated-orcid":false,"given":"Paola","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Fillit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100367_bib0001","article-title":"Alzheimer's disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100367_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100367_bib0003","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100367_bib0004","doi-asserted-by":"crossref","first-page":"e2102","DOI":"10.1212\/WNL.0000000000201043","article-title":"Beta-amyloid, tau, neurodegeneration classification and eligibility for anti-amyloid treatment in a memory clinic population","volume":"99","author":"Rosenberg","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100367_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209402","article-title":"Proportion of community-dwelling individuals older than 70 years eligible for lecanemab initiation: the gothenburg H70 birth cohort study","volume":"102","author":"Dittrich","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100367_bib0006","doi-asserted-by":"crossref","first-page":"718","DOI":"10.14283\/jpad.2023.114","article-title":"Multimodal precision prevention - a new direction in alzheimer's disease","volume":"10","author":"Barbera","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100001","article-title":"Key considerations for combination therapy in Alzheimer's clinical trials: perspectives from an expert advisory board convened by the alzheimer's drug discovery foundation","volume":"12","author":"Cummings","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0008","doi-asserted-by":"crossref","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet 404, 572-628 (2024). 10.1016\/S0140-6736(24)01296-0.","DOI":"10.1016\/S0140-6736(24)01296-0"},{"key":"10.1016\/j.tjpad.2025.100367_bib0009","unstructured":"Risk reduction of cognitive decline and dementia: WHO guidelines; geneva: world health organization; licence: CC BY-NC-SA 3.0 IGO. (2019)."},{"key":"10.1016\/j.tjpad.2025.100367_bib0010","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tjpad.2025.100367_bib0011","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaneurol.2017.4365","article-title":"Effect of the apolipoprotein e genotype on cognitive change during a multidomain lifestyle intervention: a subgroup analysis of a randomized clinical trial","volume":"75","author":"Solomon","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100367_bib0012","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/alz.13838","article-title":"Japan-multimodal intervention trial for the prevention of dementia: a randomized controlled trial","volume":"20","author":"Sakurai","year":"2024","journal-title":"J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100367_bib0013","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/alz.12123","article-title":"World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia","volume":"16","author":"Kivipelto","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100367_bib0014","article-title":"Atrial fibrillation: a review","author":"Ko","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100367_bib0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100367_bib0016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/alz.12172","article-title":"36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease","volume":"17","author":"Soininen","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100367_bib0017","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14283\/jpad.2022.4","article-title":"Multimodal preventive trial for alzheimer's disease: MIND-ADmini pilot trial study design and progress","volume":"9","author":"Sindi","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0018","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.tjpad.2025.100367_bib0019","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100367_bib0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100367_bib0021","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100367_bib0022","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-023-01355-x","article-title":"A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol","volume":"16","author":"Barbera","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100367_bib0023","first-page":"13","article-title":"Mapt Study: A Multidomain Approach for Preventing Alzheimer's Disease: Design and Baseline Data","volume":"1","author":"Vellas","year":"2014","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0024","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.01.013","article-title":"Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","volume":"6","author":"Yurko-Mauro","year":"2010","journal-title":"J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100367_bib0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/01.wnl.0000324268.45138.86","article-title":"Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial","volume":"71","author":"van de Rest","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100367_bib0026","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3945\/ajcn.2009.29121","article-title":"Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial","volume":"91","author":"Dangour","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.tjpad.2025.100367_bib0027","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/00207459609070833","article-title":"Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life","volume":"87","author":"Yehuda","year":"1996","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.tjpad.2025.100367_bib0028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12916-024-03296-0","article-title":"The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis","volume":"22","author":"Suh","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.tjpad.2025.100367_bib0029","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14737175.2024.2313547","article-title":"An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention","volume":"24","author":"Castellanos-Perilla","year":"2024","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.tjpad.2025.100367_bib0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuroimage.2015.09.050","article-title":"Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment","volume":"131","author":"Kobe","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.tjpad.2025.100367_bib0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13195-023-01325-3","article-title":"Cognitive impact of multidomain intervention and omega 3 according to blood Abeta42\/40 ratio: a subgroup analysis from the randomized MAPT trial","volume":"15","author":"Delrieu","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100367_bib0032","doi-asserted-by":"crossref","first-page":"633","DOI":"10.14283\/jpad.2023.104","article-title":"Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics","volume":"10","author":"Riessland","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0033","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuroscience.2024.09.042","article-title":"Vitamin D: The crucial neuroprotective factor for nerve cells","volume":"560","author":"Shi","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.tjpad.2025.100367_bib0034","doi-asserted-by":"crossref","first-page":"E4359","DOI":"10.1073\/pnas.1404477111","article-title":"Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats","volume":"111","author":"Latimer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tjpad.2025.100367_bib0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s11357-022-00702-4","article-title":"Frailty and functional brain connectivity (FBC) in older adults with mild cognitive impairment (MCI): baseline results from the SYNERGIC Trial","volume":"45","author":"Bray","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.tjpad.2025.100367_bib0036","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12877-018-0782-7","article-title":"SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment","volume":"18","author":"Montero-Odasso","year":"2018","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.tjpad.2025.100367_bib0037","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s11357-023-00805-6","article-title":"Combining exercise with cognitive training and vitamin D(3) to improve functional brain connectivity (FBC) in older adults with mild cognitive impairment (MCI). Results from the SYNERGIC trial","volume":"45","author":"Bray","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.tjpad.2025.100367_bib0038","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.24465","article-title":"Effects of exercise alone or combined with cognitive training and vitamin d supplementation to improve cognition in adults with mild cognitive impairment: a randomized clinical trial","volume":"6","author":"Montero-Odasso","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.tjpad.2025.100367_bib0039","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-2011-110635","article-title":"Neuroprotective effects of a specific multi-nutrient intervention against A\u03b242-induced toxicity in rats","volume":"27","author":"de Wilde","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neurobiolaging.2013.09.038","article-title":"Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease","volume":"35","author":"Zerbi","year":"2014","journal-title":"Neurobiol aging"},{"key":"10.1016\/j.tjpad.2025.100367_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2009.10.003","article-title":"Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial","volume":"6","author":"Scheltens","year":"2010","journal-title":"J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100367_bib0042","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1474-4422(17)30332-0","article-title":"24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial","volume":"16","author":"Soininen","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100367_bib0043","doi-asserted-by":"crossref","first-page":"992","DOI":"10.14283\/jpad.2024.55","article-title":"Evaluation of clinical meaningfulness of fortasyn connect in terms of \"time saved\"","volume":"11","author":"Dickson","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0044","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-024-01468-x","article-title":"Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-AD(mini) randomized controlled trial","volume":"16","author":"Thunborg","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100367_bib0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13195-024-01495-8","article-title":"A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial","volume":"16","author":"Deckers","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100367_bib0046","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.abb.2008.04.003","article-title":"(-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells","volume":"476","author":"Na","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.tjpad.2025.100367_bib0047","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fphar.2017.00834","article-title":"Diabetes mellitus and alzheimer's disease: the protection of epigallocatechin-3-gallate in streptozotocin injection-induced models","volume":"8","author":"Jia","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.tjpad.2025.100367_bib0048","first-page":"1025","article-title":"Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability","volume":"11","author":"Lee","year":"2002","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.tjpad.2025.100367_bib0049","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"15","author":"de la Torre","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100367_bib0050","article-title":"Prevention of cognitive decline in subjective cognitive decline APOE epsilon4 carriers after EGCG and a multimodal intervention (PENSA): Study design","volume":"7","author":"Forcano","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100367_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100271","article-title":"A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- varepsilon4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study)","author":"Forcano","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0052","author":"Forcano","year":"2025","journal-title":"J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100367_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102689","article-title":"Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study","volume":"73","author":"Tang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.tjpad.2025.100367_bib0054","article-title":"Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US","author":"Wang","year":"2024","journal-title":"J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100367_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40263-017-0434-z","article-title":"Elucidating the Abeta42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data","volume":"31","author":"Kocis","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tjpad.2025.100367_bib0056","first-page":"219","article-title":"Clinical benefits of tramiprosate in alzheimer's disease are associated with higher number of APOE4 alleles: The \"APOE4 gene-dose effect\"","volume":"3","author":"Abushakra","year":"2016","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0057","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40520-019-01403-3","article-title":"Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study","volume":"32","author":"Rolandi","year":"2020","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.tjpad.2025.100367_bib0058","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40520-025-03062-z","article-title":"Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trial","volume":"37","author":"Rolandi","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.tjpad.2025.100367_bib0059","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.18632\/aging.100981","article-title":"Reversal of cognitive decline in Alzheimer's disease","volume":"8","author":"Bredesen","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.tjpad.2025.100367_bib0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13195-024-01482-z","article-title":"Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial","volume":"16","author":"Ornish","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100367_bib0061","unstructured":"in Risk reduction of cognitive decline and dementia: WHO guidelines. (2019)."},{"key":"10.1016\/j.tjpad.2025.100367_bib0062","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.0b013e31824e8f0d","article-title":"Amantadine: the journey from fighting flu to treating Parkinson disease","volume":"78","author":"Hubsher","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100367_bib0063","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1249543","article-title":"Medicine. How thalidomide works against cancer","volume":"343","author":"Stewart","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tjpad.2025.100367_bib0064","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"Norgaard","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100367_bib0065","unstructured":"Eisai US. FDA approves LEQEMBI\u00ae IQLIK\u2122 (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early alzheimer's disease. (2025)."},{"key":"10.1016\/j.tjpad.2025.100367_bib0066","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0067","unstructured":"FDA. FDA approves treatment for adults with Alzheimer\u2019s disease, https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-roundup-july-2-2024 (2024)."},{"key":"10.1016\/j.tjpad.2025.100367_bib0068","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","article-title":"Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study","volume":"5","author":"Kivipelto","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2025.100367_bib0069","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1002\/alz.13101","article-title":"Latin American initiative for lifestyle intervention to prevent cognitive decline (LatAm-FINGERS): study design and harmonization","volume":"19","author":"Crivelli","year":"2023","journal-title":"J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100367_bib0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13195-025-01722-w","article-title":"The cost effectiveness of a multidomain intervention on physical, cognitive, vascular, dietary and psychosocial outcomes among community dwelling older adults with cognitive frailty in Malaysia: The AGELESS Trial","volume":"17","author":"Ponvel","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100367_bib0071","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.2025.12923","article-title":"Structured vs self-guided multidomain lifestyle interventions for global cognitive function: The US POINTER randomized clinical trial","volume":"334","author":"Baker","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100367_bib0072","article-title":"Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease","volume":"21","author":"Leuzy","year":"2025","journal-title":"J Alzheimer's Assoc"},{"key":"10.1016\/j.tjpad.2025.100367_bib0073","unstructured":"FDA. FDA clears first blood test used in diagnosing alzheimer\u2019s disease. (2025). https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease."},{"key":"10.1016\/j.tjpad.2025.100367_bib0074","doi-asserted-by":"crossref","first-page":"329","DOI":"10.14283\/jpad.2024.32","article-title":"Validation, deployment, and real-world implementation of a modular toolbox for alzheimer's disease detection and dementia risk reduction: the AD-RIDDLE project","volume":"11","author":"Malzbender","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0075","doi-asserted-by":"crossref","first-page":"729","DOI":"10.14283\/jpad.2023.111","article-title":"The critical role of biomarkers for drug development targeting the biology of aging","volume":"10","author":"Owen","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100367_bib0076","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2013study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tjpad.2025.100367_bib0077","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13195-024-01522-8","article-title":"Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer's disease: Multimodal Preventive Trial for Alzheimer's Disease (MIND-AD(mini))","volume":"16","author":"Levak","year":"2024","journal-title":"Alzheimers Res Ther"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:32:08Z","timestamp":1785972728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725003097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2274580725003097"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100367","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk reduction and precision prevention across the Alzheimer\u2019s disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100367"}}